These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14531801)

  • 1. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease.
    Salama AD; Chaudhry AN; Holthaus KA; Mosley K; Kalluri R; Sayegh MH; Lechler RI; Pusey CD; Lightstone L
    Kidney Int; 2003 Nov; 64(5):1685-94. PubMed ID: 14531801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of T cell responses to the autoantigen in Goodpasture's disease.
    Derry CJ; Ross CN; Lombardi G; Mason PD; Rees AJ; Lechler RI; Pusey CD
    Clin Exp Immunol; 1995 May; 100(2):262-8. PubMed ID: 7743665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
    Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
    Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
    Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG
    N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
    Ooi JD; Holdsworth SR; Kitching AR
    J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goodpasture's disease: a report of ten cases and a review of the literature.
    Dammacco F; Battaglia S; Gesualdo L; Racanelli V
    Autoimmun Rev; 2013 Sep; 12(11):1101-8. PubMed ID: 23806563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthy individuals have Goodpasture autoantigen-reactive T cells.
    Zou J; Hannier S; Cairns LS; Barker RN; Rees AJ; Turner AN; Phelps RG
    J Am Soc Nephrol; 2008 Feb; 19(2):396-404. PubMed ID: 18216317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1.
    Salama AD; Chaudhry AN; Ryan JJ; Eren E; Levy JB; Pusey CD; Lightstone L; Lechler RI
    J Am Soc Nephrol; 2001 Sep; 12(9):1908-1915. PubMed ID: 11518784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor.
    Dougan T; Levy JB; Salama A; George AJ; Pusey CD
    Clin Exp Immunol; 2002 Jun; 128(3):555-61. PubMed ID: 12067312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen.
    Merkel F; Kalluri R; Marx M; Enders U; Stevanovic S; Giegerich G; Neilson EG; Rammensee HG; Hudson BG; Weber M
    Kidney Int; 1996 Apr; 49(4):1127-33. PubMed ID: 8691734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis.
    Pedchenko V; Vanacore R; Hudson B
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):290-6. PubMed ID: 21378566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-GBM glomerulonephritis: a T cell-mediated autoimmune disease?
    Lou YH
    Arch Immunol Ther Exp (Warsz); 2004; 52(2):96-103. PubMed ID: 15179323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease.
    Yang R; Cui Z; Hellmark T; Segelmark M; Zhao MH; Wang HY
    Clin Immunol; 2007 Aug; 124(2):207-12. PubMed ID: 17556023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goodpasture's syndrome: a clinical update.
    Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Pagliuca G; Martellucci S; Turchetta R; Longo L; De Vincentiis M
    Autoimmun Rev; 2015 Mar; 14(3):246-53. PubMed ID: 25462583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell responses to peptides of Goodpasture autoantigen in patients with anti-glomerular basement membrane disease.
    Hu SY; Jia XY; Gu QH; Yu CY; Cheng XY; Jin QZ; Zhou FD; Cui Z; Zhao MH
    Nephrology (Carlton); 2018 Apr; 23(4):345-350. PubMed ID: 28152559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
    Savige JA; Gallicchio M
    Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
    Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
    J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
    Borza DB; Hudson BG
    Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease.
    Cairns LS; Phelps RG; Bowie L; Hall AM; Saweirs WW; Rees AJ; Barker RN
    J Am Soc Nephrol; 2003 Nov; 14(11):2801-12. PubMed ID: 14569090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.